HPV Vaccine Succeeds Against Cervical Precancers

Incidence of preliminary cervical cancer decreased by approximately 80% among women aged 20-24 years in the United States since the widespread use of the human papillomavirus (HPV) vaccine, according to new data from the Centers for Disease Control and Prevention (CDC). The HPV vaccine was first recommended in 2006 for the prevention of cancers and … Read more

HPV Vaccine ‘Very Promising’ for Nixing Precancerous Lesions

An experimental therapeutic human papillomavirus (HPV) vaccine showed promise in inducing regression of precancerous cervical lesions as well as viral clearance in patients with cervical intraepithelial neoplasia type 3 (CIN3), according to a small phase II, nonrandomized study. “If confirmed in a larger trial, our results could mean that at least half of the patients … Read more